OptimizeRx is a medical - healthcare information services company in the healthcare sector trading on NASDAQ, led by CEO Stephen L. Silvestro, with a market cap of $115.6M.
Common questions about OptimizeRx
OptimizeRx is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $18.4M.
OptimizeRx has approximately 136 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.